Total synthesis of phosphatidylinositol 3,5-bisphosphate

磷脂酰肌醇3,5-二磷酸全合成

基本信息

  • 批准号:
    13672215
  • 负责人:
  • 金额:
    $ 2.56万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

Phosphorylated phoshoinositides play pivotal roles as second messengers in intracellular signal transduction. Phosphatidylinositol 3,5-bisphosphate (PI 3,5-P2) was recently identified as novel second messenger. In this research project, phosphatidylinositol 3,5-bisphospate was synthesized by two different synthetic tactics. The first was diastereoselective synthesis from D-glucose, and the second was asymmetric desymmetrization of meso-myo-inositol derivative1. Asymmetric total synthesis of phosphatidylinositol 3,5-bisphosphate from D-glucoseThe 1,2-addition of vinyl copper reagent to the chiral aldehyde derivative fron D-glucose gave the desired diastereomer of allyl alcohol. Protection of hydroxyl group, acid hydrolysis, Wittig methylenation and ring-closing metathesis (RCM) gave the conduritol B derivatives. By catalytic OsO_4 oxidation of non-C_2 symmetric conduritol B derivatives, we could synthesize the desired diol as key intermediate of phosphatidylinositol 3,5-bisphosphate. Finally, this diol was successfully converted to phosphatidylinositol 3,5-bisphosphate by established amidite procedure2. Enantioselective desymmetrization of meso-1,2,3-TriolWe could developed the highly enatioselective one-pot desymmetrization of meso-1,2,3-triol derivatives of myo-inositol by asymmetric acylation followed by successive kinetic resolution by CuCl_2-chirat diamine complex catalyzed asymmetric benzoylation. Enantioselective desymmetrization of meso-myo-inositol derivative was successfully applied to the asymmetric total synthesis of the key intermediate of phosphatidylinositol 3,5-bisphosphate
磷酸化的磷肌苷作为第二信使在细胞内信号转导中起着关键作用。磷脂酰肌醇3,5-二磷酸(pi3,5 - p2)最近被确定为新的第二信使。本课题采用两种不同的合成策略合成了磷脂酰肌醇3,5-二磷酸。第一个是d -葡萄糖的非对映选择性合成,第二个是中肌醇衍生物的不对称去对称化。从d -葡萄糖中不对称全合成3,5-二磷酸磷脂酰肌醇乙烯基铜试剂在d -葡萄糖的手性醛衍生物上加成1,2得到所需的烯丙醇非对映体。羟基保护、酸水解、Wittig甲基化和合环复合反应(RCM)得到了孔杜糖醇B衍生物。通过OsO_4催化氧化非c_2对称孔枝糖醇B衍生物,合成了所需的二醇作为磷脂酰肌醇3,5-二磷酸的关键中间体。最后,该二醇通过建立的酰胺法成功转化为磷脂酰肌醇3,5-二磷酸2。通过不对称酰化,再通过CuCl_2-chirat二胺配合物催化不对称苯甲酰化,建立了肌醇中位1,2,3-三醇衍生物的高对映选择性一锅脱对称反应。将中肌肌醇衍生物的对映选择性去对称反应成功地应用于磷脂酰肌醇3,5-二磷酸关键中间体的不对称全合成

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Asuka Nishikawa: "Synthesis of L-α-Phosphatidyl-D-myo-inositol 3, 5-Bisphosphate from D-Glucose"Tetrahedron Letters. 42・52. 9195-9198 (2001)
Asuka Nishikawa:“从D-葡萄糖合成L-α-磷脂酰-D-肌醇3, 5-二磷酸”四面体快报42・52(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Asuka Nishikawa: "Synthesis of L-α-Phosphatigyl-D-myo-inositol 3,5-Bisphosphate from D-Glucose"Tetrahedron Letters. 42. 9195-9198 (2001)
Asuka Nishikawa:“从 D-葡萄糖合成 L-α-磷酸基-D-肌醇 3,5-二磷酸”Tetrahedron Letters 42. 9195-9198 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Asuka Nishikawa: "Synthesis of L-α-Phosphatidyl-D-myo-inositol 3,5-Bisphosphate from D-Glucose"Tetrahedron Letters. 42. 9195-9198 (2001)
Asuka Nishikawa:“从 D-葡萄糖合成 L-α-磷脂酰-D-肌醇 3,5-二磷酸”Tetrahedron Letters 42. 9195-9198 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIRAI Ryuichi其他文献

SHIRAI Ryuichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIRAI Ryuichi', 18)}}的其他基金

Total synthesis of Salinosporamide A, a potent proteasome inhibitor
强效蛋白酶体抑制剂 Salinosporamide A 的全合成
  • 批准号:
    18590023
  • 财政年份:
    2006
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Synthetic study of novel inositol phosphoceramide CJP2
新型肌醇磷酸神经酰胺CJP2的合成研究
  • 批准号:
    15590006
  • 财政年份:
    2003
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Asymmetric synthesis of proteinphosphatase inhibitor dysidiolode and its potent analogs
蛋白磷酸酶抑制剂dysidiolode及其有效类似物的不对称合成
  • 批准号:
    10671984
  • 财政年份:
    1998
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SYNTHESIS OF ANTIMITOTIC NATURAL PRODUCTS
抗有丝分裂天然产物的合成
  • 批准号:
    08672414
  • 财政年份:
    1996
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Mechanisms of PIKII-dependent transport during secretory granule biogenesis
分泌颗粒生物发生过程中 PIKII 依赖性运输的机制
  • 批准号:
    490594
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Operating Grants
A full spectrum rational approach to identify antiarrhythmic agents targeting IKs Channels
识别针对 IK 通道的抗心律失常药物的全谱理性方法
  • 批准号:
    10734513
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Unexpected roles of phosphoinositides in the nucleus
磷酸肌醇在细胞核中的意外作用
  • 批准号:
    10711033
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
PITPNA in pancreatic beta-cell dysfunction and diabetes pathogenesis
PITPNA 在胰腺 β 细胞功能障碍和糖尿病发病机制中的作用
  • 批准号:
    10636228
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Regulation of KRAS plasma membrane targeting by defined glycosphingolipids.
通过特定的鞘糖脂调节 KRAS 质膜靶向。
  • 批准号:
    10718459
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Cerebrovascular endothelial cilia in the pathogenesis and therapy of Alzheimer's disease
脑血管内皮纤毛在阿尔茨海默病发病机制和治疗中的作用
  • 批准号:
    10575082
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Discovery of allosteric activators of phospholipase C-gamma2 to treat Alzheimer's disease
发现用于治疗阿尔茨海默病的磷脂酶 C-gamma2 变构激活剂
  • 批准号:
    10901007
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Mechanisms of Pip4k2c and Pip5k1b dependencies in Ras driven squamous cell carcinoma
Ras 驱动的鳞状细胞癌中 Pip4k2c 和 Pip5k1b 依赖性的机制
  • 批准号:
    10667117
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Architecture, dynamics and regulation of erythrocyte ankyrin-1 complexes
红细胞ankyrin-1复合物的结构、动力学和调节
  • 批准号:
    10638440
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Role of StAR-related lipid transfer protein 10 in alcohol-induced breast cancer progression
StAR相关脂质转移蛋白10在酒精诱导的乳腺癌进展中的作用
  • 批准号:
    10734533
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了